6 research outputs found
Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies
- Author
- A David
- A Gajjar
- A Jimeno
- A Manoharan
- A Merchant
- A Quintás-Cardama
- A Rambaldi
- A Sekulic
- A Tefferi
- A Tefferi
- A Tefferi
- A Tefferi
- AA Merchant
- AD Pardanani
- AL Boyd
- AM Vannucchi
- AP McMahon
- B Goldenson
- B St-Jacques
- BA McIntyre
- BG Mar
- BL Scott
- C Dierks
- C Dierks
- C Harrison
- C James
- C Jamieson
- C Zhao
- CA Huff
- CD Peacock
- CI Lau
- CL Cooper
- D Amakye
- E Jabbour
- E Lofvenberg
- EJ Baxter
- F Cervantes
- F Cervantes
- F Cervantes
- F Lang
- G Barosi
- G Barosi
- GC Trudel
- I Hofmann
- I Slade
- J Astorga
- J Gao
- J Mascarenhas
- J Nangalia
- J Palis
- J Rodon
- J Xie
- JJ Trowbridge
- KH Begna
- KK Ballen
- L Mandal
- M Chaklader
- M Gering
- M Kieran
- M Kobune
- M Peeters
- M Zingariello
- MA Dyer
- MC Petti
- MR Gailani
- N Bhagwat
- N Byrd
- N Gangat
- N Kröger
- Novartis Pharmaceuticals Canada Inc
- P Guglielmelli
- P Maye
- P Thapaliya
- PM Lorusso
- PM Wong
- R Alves
- R Kralovics
- R Scherber
- R Tibes
- R Tibes
- R Tibes
- RA Mesa
- RA Mesa
- RA Mesa
- RA Mesa
- RA Mesa
- RA Mesa
- Raoul Tibes
- RL Levine
- RL Levine
- Ruben A Mesa
- S Blotta
- S Katagiri
- S Okabe
- S Teglund
- S Verstovsek
- S Verstovsek
- SJ Scales
- SL Siggins
- SO Cridland
- T Klampfl
- T Tauchi
- TL Lin
- U Tostar
- V Guadagnuolo
- W Fiskus
- XM Zhang
- Y Minami
- Y Tokusumi
- Z Jagani
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Inhaler assessment in COPD patients
- Author
- AstraZeneca Canada Inc
- AstraZeneca Canada Inc
- AstraZeneca Canada Inc
- Batterink J
- Boehringer Ingelheim Canada Ltd
- Boehringer Ingelheim Canada Ltd
- Boehringer Ingelheim Canada Ltd
- Boehringer Ingelheim Canada Ltd
- Boehringer Ingelheim Canada Ltd
- GlaxoSmithKline Inc
- GlaxoSmithKline Inc
- GlaxoSmithKline Inc
- GlaxoSmithKline Inc
- GlaxoSmithKline Inc
- Jennifer Bolt
- Novartis Pharmaceuticals Canada Inc
- Novartis Pharmaceuticals Canada Inc
- Novartis Pharmaceuticals Canada Inc
- Novartis Pharmaceuticals Canada Inc
- Pharmel Inc
- Prime D
- Sanis Health Inc
- Shelby Dougall
- Tanya Winkel
- William Semchuk
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
Evaluation of the pharmacokinetics of the simultaneous quantification of letrozole and palbociclib in rat plasma by a developed and validated HPLC–PDA
- Author
- Publication venue
- 'Akademiai Kiado Zrt.'
- Publication date
- Field of study
Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective
- Author
- Baraliakos X
- Boonen A
- Braun JBX
- CADTH Guidelines
- Corbett MSM
- Dias S
- Djambazov S
- Garrett S
- Heuft-Dorenbosch L
- Kobelt G
- Maksymowych W
- Maksymowych WP
- Marzo-Ortega H
- Minal Jain
- NICE.
- NICE.
- Novartis Pharmaceuticals Canada Inc
- Pavelka K
- Praveen Gunda
- Rohekar S
- Ron Goeree
- Sima Chiva-Razavi
- Statistics Canada
- Statistics Canada
- Steffen M. Jugl
- Taurog JD
- Publication venue
- 'Informa UK Limited'
- Publication date
- Field of study
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
- Author
- A Constant
- A Knott
- A Kunze
- A Scalori
- A Schaffer
- A Wasley
- AH Andreasen
- AI Nichols
- Alice Tseng
- AM Matthews
- AP Rajkumar
- AstraZeneca Canada Inc
- B Dbouk
- B Eiermann
- BA English
- BJ Morasco
- BJ Morasco
- BL Felker
- BR Bacon
- C Kasserra
- C Maddock
- C Marzolini
- CU Onyike
- D Telio
- DA Flockhart
- David Wong
- DJ Moore
- DL Sylvestre
- DW Boulton
- E Dieperink
- E Dieperink
- E Spina
- EGJ Hulskotte
- EGJ Hulskotte
- EGJ Hulskotte
- EP Harrigan
- F Poordad
- FP Guengerich
- G Garcia-Pares
- G Kipp
- H Hachad
- HB El-Sarag
- IM Jacobson
- J Grebely
- J Thome
- K Ademmer
- KE Sherman
- LN Yatham
- Lundbeck Canada Inc
- Lundbeck Canada Inc
- M Huckans
- M Schaefer
- M Schaefer
- M Schaefer
- M Schafer
- MA Rifai
- Merck Canada Inc
- Merck Canada Inc. MC
- MP Manns
- MW Fried
- N Horikawa
- Novartis Pharmaceuticals Canada Inc
- O Freudenreich
- OC Gleason
- OC Gleason
- OC Gleason
- OC Gleason
- P Hauser
- Pierre Giguere
- PM Huet
- PR Powell-Jackson
- PY Kwo
- R Ramasubbu
- RG Hoffman
- RP Swinson
- RPG Van Heeswijk
- S Baraldi
- S Hosoda
- S Neri
- S Sockalingam
- S Sockalingam
- S Sockalingam
- S Sockalingam
- S Sockalingam
- S Zeuzem
- Sanjeev Sockalingam
- SF Zhou
- SP Yovtcheva
- T Liukkonen
- UA Argikar
- V Garg
- Vertex Pharmaceuticals Inc
- VM Castro
- W DeMaio
- X Luo
- X Luo
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
- Author
- Alvarez GG
- Asthma UK
- Barton P
- Brown R
- Bucknall CE
- Burr ML
- Clark W
- Clark W
- Dewilde S
- European Respiratory Society and the European Lung Foundation
- Forbes RB
- Global Initiative for Asthma
- Global Strategy for Asthma Management and Prevention
- Graf von der Schulenburg JM
- Guite HF
- Hartert TV
- Hooi LN
- Hoskins G
- Humbert M
- Jaisson-Hot I
- Jobanputra P
- Juniper EF
- Lanier BQ
- Marshall J
- McCowan C
- McCowan C
- Mohan G
- National Institute For Health And Clinical Excellence
- Natonal Institute for Health and Clinical Excellence
- Niven R
- Novartis Pharmaceutical Canada Inc.
- Novartis Pharmaceuticals Corp
- Otten N
- Rea HH
- Redd SC
- Turk F
- United States Bureau of Labor Statistics
- World Health Organization
- Publication venue
- 'Wiley'
- Publication date
- Field of study